What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Immune system
His primary areas of investigation include Immunology, Dendritic cell, Inflammation, Immune system and Allergy.
His work on Immunology deals in particular with Cytokine, Eosinophil, Antigen presentation, Antigen and Adoptive cell transfer.
His Dendritic cell research includes themes of T cell, Antigen-presenting cell, Cancer research and Priming.
He usually deals with Inflammation and limits it to topics linked to Interleukin and Peroxisome proliferator-activated receptor and Eotaxin.
His research in the fields of Immune tolerance and Immunotherapy overlaps with other disciplines such as Purinergic signalling.
His research investigates the connection between Allergy and topics such as Asthma that intersect with problems in Respiratory disease.
His most cited work include:
- An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline (915 citations)
- Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells (769 citations)
- Essential Role of Lung Plasmacytoid Dendritic Cells in Preventing Asthmatic Reactions to Harmless Inhaled Antigen (707 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Immunology, Internal medicine, Pathology, Dendritic cell and Inflammation.
His Immunology research focuses on Bronchoalveolar lavage and how it relates to Extrinsic Allergic Alveolitis.
His biological study spans a wide range of topics, including Gastroenterology, Endocrinology, Surgery and Oncology.
His Pathology research incorporates elements of Respiratory disease and Lung.
His Dendritic cell study integrates concerns from other disciplines, such as Eosinophil, T cell, Antigen presentation, Antigen-presenting cell and Immunotherapy.
His work deals with themes such as Cytotoxic T cell, Antibody and Molecular biology, which intersect with Antigen.
He most often published in these fields:
- Immunology (45.49%)
- Internal medicine (23.83%)
- Pathology (19.13%)
What were the highlights of his more recent work (between 2011-2018)?
- Immunology (45.49%)
- Internal medicine (23.83%)
- Sarcoidosis (6.50%)
In recent papers he was focusing on the following fields of study:
Henk C. Hoogsteden mainly focuses on Immunology, Internal medicine, Sarcoidosis, Pathology and Immune system.
His Immunology research focuses on Cytokine, Inflammation, Dendritic cell, Immunotherapy and Interleukin.
His Cytokine research focuses on T cell and how it connects with Eosinophil.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Surgery and Oncology.
His Immune system research incorporates themes from Lung cancer, Antibody, Disease and Antigen.
His research integrates issues of Cytotoxic T cell and Molecular biology in his study of Antigen.
Between 2011 and 2018, his most popular works were:
- An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline (915 citations)
- Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial (159 citations)
- Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis (103 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Immune system
Henk C. Hoogsteden mostly deals with Immunology, Dendritic cell, Cytokine, Pathology and Peripheral blood mononuclear cell.
His Immunology study combines topics in areas such as Internal medicine and Bronchoalveolar lavage.
His Dendritic cell research is multidisciplinary, incorporating perspectives in Eosinophil, Mesothelioma, Degranulation, Pharmacology and Immunotherapy.
His Interleukin study in the realm of Cytokine interacts with subjects such as Farnesoid X receptor.
Henk C. Hoogsteden has researched Pathology in several fields, including M2 Macrophage, CD163, Induction chemotherapy and Predictive marker.
He has included themes like Immunophenotyping, Innate lymphoid cell, Allergy and Asthma in his Inflammation study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
